International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 3 , Pages 773-783 , 1 July 2010

Late Gastrointestinal Toxicity After Dose-Escalated Conformal Radiotherapy for Early Prostate Cancer: Results From the UK Medical Research Council RT01 Trial (ISRCTN47772397)

  • Isabel Syndikus, F.R.C.R.

      Affiliations

    • Clatterbridge Centre for Oncology, Bebington, United Kingdom
    • ,
  • Rachel C. Morgan, M.Sc.

      Affiliations

    • Cancer Group, MRC Clinical Trials Unit, London, United Kingdom
    • ,
  • Matthew R. Sydes, C.Stat.

      Affiliations

    • Cancer Group, MRC Clinical Trials Unit, London, United Kingdom
    • Corresponding Author InformationReprint requests to: Matthew R.Sydes, MRC Clinical Trials Unit, 222 Euston Road, London NW1 2DA, United Kingdom. Tel.: (+44) 208 670 4798; Fax: (+44) 208 670 4818
    • ,
  • John D. Graham, F.R.C.R.

      Affiliations

    • Taunton and Somerset NHS Foundation Trust, Musgrove Park Hospital, Taunton, United Kingdom
    • ,
  • David P. Dearnaley, F.R.C.R.

      Affiliations

    • Institute of Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom
    • ,
  • MRC RT01 collaborators

Received 27 January 2009 ,Revised 21 May 2009 ,Accepted 27 May 2009.

References 

  1. Kuban DA, Tucker SL, Dong L, et al. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70:67–74
  2. Peeters STH, Heemsbergen WD, Koper PC, et al. Dose response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter phase III randomized trial comparing 68 Gy with 78 Gy. J Clin Oncol. 2006;24:1990–1906
  3. Al-Mamgani A, Van Putten WLJ, Heemsbergen WD, et al. Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008;72:980–988
  4. Zietman AL, DeSilvio ML, Slater JD, et al. Comparison of conventional-dose versus high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate. JAMA. 2005;294:1233–1239
  5. Dearnaley DP, Hall E, Lawrence D, et al. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br J Cancer. 2005;92:488–498
  6. Dearnaley DP, Sydes MR, Langley RE, et al. The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localized prostate cancer: Results from the MRC RT01 trial (ISRCTN47772397). Radiother Oncol. 2007;83:31–41
  7. Dearnaley DP, Sydes MR, Graham JD, et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial. Lancet Oncol. 2007;8:475–487
  8. Sydes MR, Stephens R, Moore A, et al. Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): Methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer. Radiother Oncol. 2004;72:199–211
  9. Brenner H, Arndt V. Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: Population-based estimates for the year 2000 by period analysis. J Clin Oncol. 2005;23:441–447
  10. Pilepich MV, Asbell SO, Krall JM, et al. Correlation of radiotherapeutic parameters and treatment related morbidity–analysis of RTOG Study 77-06. Int J Radiat Oncol Biol Phys. 1987;13:1007–1012
  11. LENT SOMA tables. Radiother Oncol. 1995;35:17–60
  12. Litwin MS, Hays RD, Fink A, et al. The UCLA prostate cancer index: Development, reliability, and validity of a health-related quality of life measure. Med Care. 1998;36:1002–1012
  13. Esper P, Mo F, Chodak G, et al. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology. 1997;50:920–928
  14. Koper PC, Heemsbergen WD, Hoogeman MS, et al. Impact of volume and location of the irradiated rectum wall on rectal blood loss after radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys. 2004;58:1072–1082
  15. Michalski JM, Winter K, Purdy JA, et al. Toxicity after three–dimensional radiotherapy for prostate cancer on RTOG 9406 dose level V. Int J Radiat Oncol Biol Phys. 2005;62:706–713
  16. Geinitz H, Zimmerman FB, Thamm R, et al. Late rectal symptoms and quality of life after conformal radiation therapy for prostate cancer. Radiother Oncol. 2006;79:341–347
  17. Chan LW, Ping X, Gottschalk AR, et al. Proposed rectal dose constraints for patients undergoing definite whole pelvic radiotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008;72:69–77
  18. Heemsbergen WD, Hoogeman MS, Hart GA, et al. Gastrointestinal toxicity and its relation to dose distributions in the anorectal region of prostate cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2005;61:1011–1018
  19. DeCrevoisieur R, Tucker S, Dong L, et al. Increased risk of biochemical and local failure in patients with distended rectum on the CT planning for prostate radiotherapy. Int J Radiat Oncol Biol Phys. 2005;62:965–973
  20. Heemsbergen WD, Hoogeman MS, Witte MG, et al. Increased risk of biochemical and clinical failure for prostate patients with a large rectum at radiotherapy planning: Results from the Dutch trial of 68 Gy versus 78 Gy. Int J Radiat Oncol Biol Phys. 2007;67:1418–1423
  21. Skala M, Rosewall T, Dawson L, et al. Patient-assessed late toxicity rates and principal component analysis after image-guided radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2007;68:690–698
  22. Van Der Laan HP, Van Den Bergh A, Schilstra C, et al. Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70:1138–1145
  23. Andreyev HJ, Vlavianos P, Blake P, Dearnaley D. Gastrointestinal symptoms after pelvic radiotherapy: Role for the gastroenterologist. Int J Radiat Oncol Biol Phys. 2005;62:1464–1471
  24. Henderson A, Andreyev HJN, Stephens R, Dearnaley D. Patient and physician reporting of symptoms and health-related quality of life in trials of treatment for early prostate cancer: Consideration for future studies. Clin Oncol. 2006;18:735–743
  25. Hanlon A, Schultheiss TE, Hunt MA, et al. Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. Int J Radiat Oncol Biol Phys. 1997;38:59–63
  26. Livsey JE, Routledge J, Burns M, et al. Scoring of treatment-related late effects in prostate cancer. Radiother Oncol. 2002;65:109–121
  27. Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358:1250–1261
  28. Tol-Geerdink JJ, Leer JW, van Lin EN, et al. Offering a treatment choice in the irradiation of prostate cancer leads to better informed and more active patients, without harm to well-being. Int J Radiat Oncol Biol Phys. 2008;70:42–48
  29. McNair HA, Hansen VN, Parker CC, et al. A comparison of the use of bony anatomy and internal markers for offline verification and an evaluation of the potential benefit of online and offline verification protocols for prostate radiotherapy. Int J Radiat Oncol Biol Phys. 2008;71:41–50
  30. Gulliford SL, Foo K, Morgan RC, et al. Dose-volume constraints to reduce rectal side effects from prostate radiotherapy: Evidence from the MRC RT01 trial ISRCTN 47772397. Int J Radiat Oncol Biol Phys. 2009;In press
  31. Fonteyne V, Villeirs G, Speleers B, et al. Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion. Int J Radiat Oncol Biol Phys. 2008;72:799–807

 This trial was supported by the Medical Research Council, London, UK.

 Conflicts of interest: none.

PII: S0360-3016(09)00874-8

doi: 10.1016/j.ijrobp.2009.05.052

International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 3 , Pages 773-783 , 1 July 2010

Article Tools

* Image Usage & Resolution